LEXXW vs RJF · rev $705.9K vs rev $15.91B
Lexaria Bioscience Corp (LEXXW) versus RJF (RJF) — a side-by-side from cached financials, not a winner call.
Lexaria Bioscience Corp (LEXXW) common stock listed on US.
RJF (RJF) common stock.
Latest reported LEXXW revenue for 2025-08-31 was $705.9K. Net income was -$11.9M. Revenue was up 52.0% from 2024-08-31 to 2025-08-31. LEXXW currently screens at market cap $33.8M.
Latest reported RJF revenue for 2025-09-30 was $15.91B. Net income was $2.13B. Revenue was up 6.6% from 2024-09-30 to 2025-09-30. RJF currently screens at market cap $0.
LEXXW currently screens at market cap $33.8M. RJF currently screens at market cap $0.
Not investment advice. Open the LEXXW and RJF stock pages for the full models.
Not investment advice.